Neuroscience services and drug development company NeuroDiscovery Ltd has announced that its 100 per cent owned subsidiary, NeuroSolutions Ltd, has struck a $1 million deal with a US pharmaceutical company.

Neuroscience services and drug development company NeuroDiscovery Ltd has announced that its 100 per cent owned subsidiary, NeuroSolutions Ltd, has struck a $1 million deal with a US pharmaceutical company.